Mediaura Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 10 Months
About Mediaura Biomed
Mediaura Biomed Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2022 (Two years and ten months 3 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohan Kumbhar, Avinash Deshmukh, Amit Mavle, and Two other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290PN2022PTC210582
- Company No.
210582
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Mediaura Biomed?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Mavle  | Director | 21-Apr-2022 | Current |
| Mohan Kumbhar | Director | 21-Apr-2022 | Current |
| Avinash Deshmukh | Director | 21-Apr-2022 | Current |
| Bhushan Bodade | Director | 21-Apr-2022 | Current |
| Rameshwar Somwanshi | Director | 21-Apr-2022 | Current |
Financial Performance of Mediaura Biomed.
Enhance accessibility to Mediaura Biomed's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mediaura Biomed?
Unlock access to Mediaura Biomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avirav Sciences Private LimitedAvinash Deshmukh and Amit Mavle are mutual person
Deshmukh Social FoundationAvinash Deshmukh is a mutual person
- Crasu Pharma Private Limited
Bhushan Bodade is a mutual person
- Shravanee Constructions Private Limited
Rameshwar Somwanshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediaura Biomed?
Mediaura Biomed has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediaura Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediaura Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.